Latest Regulatory Approval News

Forrestania Resources has announced a JORC-compliant Mineral Resource Estimate of 103,500 ounces of gold at its Johnson Range Project, fulfilling a key condition for acquiring Aurumin Johnson Range Pty Ltd and Aurumin Mt Dimer Pty Ltd from Newcam Minerals.

Recce Pharmaceuticals has expanded its intellectual property footprint with a newly granted patent in Brazil, protecting its innovative synthetic anti-infectives against a broad range of infections. This milestone strengthens Recce’s position in one of South America’s largest antibiotic markets.

Native Mineral Resources (ASX: NMR) has updated its drilling results at the Podosky deposit in Queensland, confirming shallow, high-grade gold mineralisation that supports near-term open-pit mining plans. Mining activities are targeted to commence in April 2026.

Avira Resources has validated significant high-grade gold intersections at its Mt Cattlin Gold Project, underpinning plans for a maiden Mineral Resource Estimate by the end of 2026. The company is poised to commence drilling in Q2 to test extensions across multiple prospects.

Clover Corporation has reported a robust first half for FY26, with revenue climbing 17% and margins expanding significantly, underpinning a confident revenue forecast for the full year.

Peppermint Innovation Limited reported a $1.27 million net loss for the half-year ending December 2025 while achieving key milestones including activation of national payment rails in the Philippines and settling a statutory demand that led to an ASX trading suspension.

Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.

LCL Resources has secured a transformative farm-in deal with Rio Tinto, which could see the mining giant earn up to an 80% stake in the promising Ono Project through substantial exploration funding and milestone payments.

Nexsen Limited has successfully completed a pivotal FDA Pre-Submission meeting for its StrepSure® diagnostic, significantly reducing regulatory risks and advancing its entry into the large US maternal health market.

St Barbara Limited is on track to complete key transactions with Lingbao Gold Group and Kumul Mineral Holdings, unlocking A$370 million in cash and advancing the New Simberi Gold Project.

Insignia Financial has secured a crucial regulatory approval from APRA, advancing the proposed acquisition by Daintree BidCo. The deal now moves closer to a shareholder vote scheduled for mid-April.

EVE Health Group has announced a $1.3 million capital raising through a placement of shares and free attaching options, aimed at advancing its pharmaceutical product rollout and development pipeline. Several components of the offer await shareholder approval at an upcoming general meeting.